10
Nov
Nov
“Short term volatility creates long term opportunity, said Rupal Bhansali, of the Ariel International Fund.
OpenAI’s top executives were engaged in a frantic damage control effort throughout Thursday, racing to contain widespread alarm over the artificial intelligence company’s financial strategy after its Chief Financial Officer, Sarah Friar, publicly suggested that the U.S. government could “backstop” the firm’s massive funding deals. The initial suggestion, made during an interview at a Wall […]
Mad Hedge Technology Letter November 7, 2025 Fiat Lux Featured Trade: (EXPENSIVE ENERGY A BIG WORRY FOR THE FUTURE OF AI) (AI)
(WHERE HUMANS OUTMANOEUVRE AI IN THE BUSINESS WORLD) November 7, 2025 Hello everyone Human beings can outdo AI on many levels. Here are a few: Storytelling in the age of AI– the data is present, but the human being turns it into a narrative that can transform a product into a […]
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but on rare occasions, it will be to exercise a STOP LOSS at a predetermined price […]
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but on rare occasions, it will be to exercise a STOP LOSS at a predetermined price […]
Global Market Comments November 7, 2025 Fiat Lux Featured Trade: (TESTIMONIAL) (CONTANGO IN THE VIX EXPLAINED ONE MORE TIME), (UVXY), ($VIX), (SPY)
07
Nov
Nov
I just wanted to drop you a note and let you know how much I enjoy reading my daily emails from you. You provide tons of information in a clear manner – with humor thrown in to boot! Great ideas for longer term investing that have more than paid for my yearly subscription already. Keep […]
Mad Hedge Biotech and Healthcare Letter November 6, 2025 Fiat Lux Featured Trade: (BLOOD SIMPLE) (GH)
At a biotech conference in San Francisco a few years ago, I found myself seated next to a young, eager analyst from a mid-tier hedge fund. He asked me if I thought liquid biopsy was “a real thing” or just another Silicon Valley mirage. I told him to watch Guardant Health (GH). If they cracked […]